Anxiety
Conditions
Keywords
anxiety, breathwork, meditation, feasibility, mobile app
Brief summary
The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults. Participants will: Use the FlowMD app daily to complete a 1-5 minute guided breathwork session over the course of 4 weeks. Complete surveys at the beginning, midpoint, and end of the study to measure anxiety levels and usability of the app.
Interventions
OTHERIntervention
4 weeks daily usage of FlowMD guided breathwork sessions
Sponsors
National University of Natural Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Are 18-65 years old * Have an anxiety disorder * Have a smartphone * Able to download the FlowMD app * Willing to use the FlowMD meditation app for a daily 1-5 minute session for four consecutive weeks * Able to provide feedback on the experience using the app * Willing to participate in surveys to measure changes in anxiety levels
Exclusion criteria
* Are undergoing significant changes in psychiatric medication or therapy * Have severe psychiatric conditions that might interfere with study participation (Schizophrenia, Bipolar Disorder, Major Depressive Disorder)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of the FlowMD mobile app | From enrollment to end of intervention at 4 weeks | Outcome measured using the Feasibility Survey with a Max Score of 32 indicating strong feasibility |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Generalized Anxiety Disorder-7 (GAD-7) Score | From Enrollment to the end of the intervention at 4 weeks | Outcome measured using the Generalized Anxiety Disorder-7 (GAD-7) survey. Score scale 0-21. Lower score indicates condition improvement. |
| Hamilton Anxiety Rating Scale (HAM-A) Score | From Enrollment to the end of the intervention at 4 weeks | Outcome measured using the Hamilton Anxiety Rating Scale (HAM-A) survey. Score scale 0-56. Lower score indicates condition improvement. |
| State-Trait Anxiety Inventory (STAI) | From Enrollment to the end of the intervention at 4 weeks | Outcome measured using the State-Trait Anxiety Inventory (STAI) survey. Score scale 20-80. Lower score indicates condition improvement. |
Countries
United States
Contacts
CONTACTMichelle T Berg, Master of Clinical Research
PRINCIPAL_INVESTIGATORHeather Zwickey, PhD
National University of Natural Medicine
Outcome results
None listed